0
0

Cart (0)

Home > NDSRI's > Tamsulosin

Tamsulosin - NDSRI's

References
FAQ's

References

  1. Niigata, Kunihiro; Fujikura, Takashi, Sulfamoyl-substituted phenethylamine derivatives, their preparation, and pharmaceutical compositions, containing them, Yamanouchi Pharmaceutical Co., Ltd., US4731478A, March 15, 1988
  2. Matsushima, Hiroshi; Takanuki, Ken-ichi; Kamimura, Hidetaka; Watanabe, Takashi; Higuchi, Saburo, Highly sensitive method for the determination of tamsulosin hydrochloride in human plasma dialyzate, plasma and urine by high-performance liquid chromatography-electrospray tandem mass spectrometry, Journal of Chromatography B: Biomedical Sciences and Applications, Volume: 695, Issue: 2, Pages: 317-327, 1997

Frequently Asked Questions

Impurities in Tamsulosin can be detected using analytical techniques like High-Performance Liquid Chromatography (HPLC).

The presence of impurities in Tamsulosin can affect patient safety. The type and level of these impurities can lead to adverse effects or diminish the effectiveness of the medication.

Acetonitrile is used to achieve optimal solubility and separation of Tamsulosin impurities.

Tamsulosin impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart
jQuery(window).on('load', function() { $('input[name="productname"]').val($('.product_title').html()); });